FR2852967B1 - Procede d'obtention de cellules dendritiques et de cellules t - Google Patents

Procede d'obtention de cellules dendritiques et de cellules t

Info

Publication number
FR2852967B1
FR2852967B1 FR0303700A FR0303700A FR2852967B1 FR 2852967 B1 FR2852967 B1 FR 2852967B1 FR 0303700 A FR0303700 A FR 0303700A FR 0303700 A FR0303700 A FR 0303700A FR 2852967 B1 FR2852967 B1 FR 2852967B1
Authority
FR
France
Prior art keywords
cells
obtaining dendritic
dendritic cells
obtaining
dendritic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0303700A
Other languages
English (en)
Other versions
FR2852967A1 (fr
Inventor
Herve Groux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sangamo Therapeutics SA
Original Assignee
TxCell SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TxCell SA filed Critical TxCell SA
Priority to FR0303700A priority Critical patent/FR2852967B1/fr
Priority to PCT/FR2004/000770 priority patent/WO2004087899A1/fr
Publication of FR2852967A1 publication Critical patent/FR2852967A1/fr
Application granted granted Critical
Publication of FR2852967B1 publication Critical patent/FR2852967B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/35—Cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C12N5/064—Immunosuppressive dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/25—Tumour necrosing factors [TNF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR0303700A 2003-03-26 2003-03-26 Procede d'obtention de cellules dendritiques et de cellules t Expired - Fee Related FR2852967B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0303700A FR2852967B1 (fr) 2003-03-26 2003-03-26 Procede d'obtention de cellules dendritiques et de cellules t
PCT/FR2004/000770 WO2004087899A1 (fr) 2003-03-26 2004-03-26 Procede d’obtention de cellules dendritiques et de cellules t regulatrices

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0303700A FR2852967B1 (fr) 2003-03-26 2003-03-26 Procede d'obtention de cellules dendritiques et de cellules t

Publications (2)

Publication Number Publication Date
FR2852967A1 FR2852967A1 (fr) 2004-10-01
FR2852967B1 true FR2852967B1 (fr) 2007-12-07

Family

ID=32947173

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0303700A Expired - Fee Related FR2852967B1 (fr) 2003-03-26 2003-03-26 Procede d'obtention de cellules dendritiques et de cellules t

Country Status (2)

Country Link
FR (1) FR2852967B1 (fr)
WO (1) WO2004087899A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9234174B2 (en) 2006-05-12 2016-01-12 Ospedale San Raffaele S.R.L. Tolerogenic dendritic cells, method for their production and uses therof
CA2877286C (fr) 2012-06-18 2023-05-16 Yale University Compositions et procedes pour faire diminuer une reponse immunitaire

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277635B1 (en) * 1992-03-04 2001-08-21 Schering Corporation Use of interleukin-10 to produce a population of suppressor cells
FR2824567B1 (fr) * 2001-05-11 2003-08-08 Inst Nat Sante Rech Med Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene

Also Published As

Publication number Publication date
FR2852967A1 (fr) 2004-10-01
WO2004087899A1 (fr) 2004-10-14

Similar Documents

Publication Publication Date Title
EP1596427A4 (fr) Procede d'introduction d'impuretes
FR2873685B1 (fr) Procede d'obtention de ceramiques poreuses
EP1576131A4 (fr) Motifs d'expression de cellules endotheliales cerebrales
EP1749319A4 (fr) Cellule electrochimique mince, souple et imprimable, et son procede d'obtention
FR2828408B1 (fr) Procede de formation d'implant
EP1587156A4 (fr) Materiau d'electrode positive pour accumulateur au lithium et procede permettant de produire ce materiau
FR2844948B1 (fr) Procede d'archivage de messages multimedias
FR2810996B1 (fr) Procede d'electrolyse
EP1661228A4 (fr) Ensembles d'excitation et procede permettant de produire ceux-ci
EP1599565A4 (fr) Procede de briquetage
FR2837385B1 (fr) Procede d'obtention de phytoalexines
MA25677A1 (fr) Dispositif et procede pour la preparation de cellules indifferenciees
EP1914196A4 (fr) Groupes quantiques atomiques stables et procede d'obtention et d'utilisation de ceux-ci
EP1471176A4 (fr) Procede et dispositif de production d'electret
EP1546361A4 (fr) Cellules autostimulantes et procede pour leur production et leur utilisation
EP1496110A4 (fr) Procede assurant la proliferation des hepatocytes humains et procede d'obtention d'hepatocytes humains
EP1539242A4 (fr) Composition et procede accroissant et maintenant la production de neurotransmetteurs
FR2843479B1 (fr) Procede de calibrage d'audio-intonation
EP1899198A4 (fr) Mecanisme de retenue liberable et procede d'utilisation
FR2836923B1 (fr) Support pour culture de cellules et procede pour cultiver des cellules.
EP1611208A4 (fr) Procede d'amelioration de fluorescence
EP1623717A4 (fr) Composition contre l'infection due au rotavirus et procede de production associe
FR2852967B1 (fr) Procede d'obtention de cellules dendritiques et de cellules t
FR2859877B1 (fr) Table et procede d'elevage de coquillages
EP1637883A4 (fr) Procede d'imunochromatographie

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20151130